Aim Bulletin
Image Scan launches portable security x-ray product
Security and industrial x-ray imaging technology company Image Scan announced the market launch of the ‘ThreatScan-AS1’ integrated portable x-Ray system for bomb squads and security professionals on Wednesday.
Phoenix Copper pleased with latest results from Red Star
United States-focussed base and precious metals explorer and producer Phoenix Copper announced the assay results from additional drilling at the Red Star silver-lead deposit, adjacent to the Empire Mine open pit project in Idaho’s Custer County on Wednesday.
Mpac ends strong year in line with expectations
Packaging and automation technology company Mpac reported a “strong” financial year in a trading update on Wednesday, saying it expected to report revenue, underlying profit before tax and closing cash in line with market expectations.
CyanConnode on track to meet full-year forecasts
Smart narrowband mesh network technology company CyanConnode said in a trading update on Wednesday that turnover for the first nine months of its financial year totalled £6. 8m, up from £3. 4m year-on-year.
Pantheon Resources gets approval for upcoming Theta West 1 well
Oil and gas company Pantheon Resources said on Wednesday that the drilling permit for Theta West 1 had now been approved.
Frontier Developments swings to first-half operating loss
Video games developer and publisher Frontier Developments reported a 33% improvement in first-half revenue year-on-year in its interim results on Wednesday, to £49. 1m, although higher costs saw it swing to an operating loss.
Continued demand sees Gamma end year strongly
Unified communications-as-a-service provider Gamma reported continued strong demand in the UK and Europe business markets for its portfolio of products in a trading update on Wednesday, which through both direct and indirect channels had performed well through the year just ended.
AB Dynamics trading remains consistent with forecasts
Testing, simulation and measurement product company AB Dynamics said in an update on Wednesday that trading during the first four months of the 2022 financial year was consistent with its expectations outlined in its results in November.
Clinigen reiterates guidance after 'solid' first half
Pharmaceutical products and services company Clinigen reiterated its guidance for EBITDA growth in the 2022 financial year of between 5% and 10% in a trading update on Wednesday.
Portmeirion delivers 'excellent' seasonal trading performance
Homewares distributor Portmeirion Group said on Wednesday that it had experienced an "excellent Christmas seasonal trading period", with "very high" global demand for consumer brands and strong sell-through across its key channels.